Rosalind Advisors, Inc. Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001622627

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2026 · 39 positions · Total reported value $244.66M · Top-10 concentration 74.5% · Updated 2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

Turnover: 54.8% · 9 new · 11 cut · 3 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +4.7% · vs SPY +2.5% · Prev Value $269.06M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -5.8% · vs SPY -7.9% · Latest Value $244.66M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Rosalind Advisors, Inc. disclosed 39 equity positions with a combined reported value of $244.66M. The filing implies a focused portfolio: its ten largest positions account for 74.5% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were DCTH ($52.71M), FENC ($33.95M), HELP ($17.06M). By sector, the heaviest allocations are Health Care 99.9%, Industrials 0.0%. Versus the prior quarter, allocation shifted toward Health Care (+5.1pp) and away from Industrials (-5.2pp).

Versus the prior quarter, Rosalind Advisors, Inc. opened 9 new positions, trimmed 11 and fully exited 3, a turnover rate of 54.8% of positions. The portfolio's overlap with the prior quarter was 71% of names.

The largest new positions opened in Q3 2026 were REPL ($13.24M), TARA ($7.32M), RCKT ($5.79M).

Of the 3 positions fully exited versus the prior quarter, the largest were CLDX ($7.44M), ELDN ($130.78K), TENX ($13.95K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • REPL REPLIMUNE GROUP INC · $13.24M
  • TARA PROTARA THERAPEUTICS INC · $7.32M
  • RCKT ROCKET PHARMACEUTICALS INC · $5.79M
  • ABOS ACUMEN PHARMACEUTICALS INC · $2.44M
  • FEMY FEMASYS INC · $1.64M
  • GRCE GRACE THERAPEUTICS INC · $1.02M
  • QQQ INVESCO QQQ TR · $257.50K
  • BMY BRISTOL-MYERS SQUIBB CO · $84.20K

Fully Exited (vs previous quarter)

  • CLDX CELLDEX THERAPEUTICS INC NEW · prev qtr: $7.44M
  • ELDN ELEDON PHARMACEUTICALS INC · prev qtr: $130.78K
  • TENX TENAX THERAPEUTICS INC · prev qtr: $13.95K

Insider Transactions (Form 4)

Latest Rosalind Advisors, Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-13 J DELCATH SYSTEMS, INC. 27,502 — SEC filing
2026-10-13 Conversion DELCATH SYSTEMS, INC. 3,627 — SEC filing

All insider transactions →

Fund Profile

Rosalind Advisors, Inc. is an SEC-registered 13F filer. As of Q2 2026 it reported 33 US equity positions with a combined value of $269.06M. HoldingsHub carries 11 quarters of its filings (Q4 2023–Q2 2026).

Portfolio Structure

  • 33 positions · $269.06M reported value (Q2 2026)
  • Top 10 holdings = 74.1% of reported value
  • Largest position: DCTH (DELCATH SYS INC) at 15.4%
  • Average position size: $8.15M

Sector Tilt

  • Health Care 94.7%
  • Industrials 5.3%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 6 new, 7 added, 12 reduced, 8 exited
  • 8 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 99.9%
Other 0.1%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 3.30M $52.71M 21.54%
21.54%
Hold
2 3.19M $33.95M 13.88%
13.88%
Hold
3 1.39M $17.06M 6.97%
6.97%
Reduce
4 3.18M $16.40M 6.70%
6.70%
Hold
5 1.00M $13.24M 5.41%
5.41%
New
6 609.20K $11.62M 4.75%
4.75%
Reduce
7 749.05K $10.31M 4.22%
4.22%
Hold
8 3.21M $9.32M 3.81%
3.81%
Hold
9 2.00M $9.26M 3.79%
3.79%
Add
10 149.36K $8.50M 3.47%
3.47%
Reduce
11 2.40M $7.32M 2.99%
2.99%
New
12 3.92M $6.11M 2.50%
2.50%
Add
13 721.50K $6.01M 2.46%
2.46%
Hold
14 2.20M $5.79M 2.37%
2.37%
New
15 828.12K $4.80M 1.96%
1.96%
Hold
16 4.13M $4.80M 1.96%
1.96%
Reduce
17 548.12K $4.04M 1.65%
1.65%
Add
18 1.11M $2.76M 1.13%
1.13%
Hold
19 3.91M $2.62M 1.07%
1.07%
Hold
20 1.10M $2.44M 1.00%
1.00%
New
21 20.87K $2.07M 0.84%
0.84%
Hold
22 1.79M $1.93M 0.79%
0.79%
Add
23 759.21K $1.64M 0.67%
0.67%
New
24 280.06K $1.46M 0.60%
0.60%
Reduce
25 20.00K $1.42M 0.58%
0.58%
Reduce
26 26.52K $1.29M 0.53%
0.53%
Add
27 701.68K $1.27M 0.52%
0.52%
Hold
28 100.00K $1.07M 0.44%
0.44%
Hold
29 476.19K $1.02M 0.42%
0.42%
New
30 177.01K $932.85K 0.38%
0.38%
Reduce
31 293.60K $356.54K 0.15%
0.15%
Reduce
32 50.00K $257.50K 0.10%
0.10%
New
33 412.70K $256.88K 0.10%
0.10%
Add
34 67.51K $183.95K 0.07%
0.07%
Reduce
35 400.00K $160.00K 0.07%
0.07%
Reduce
36 618.80K $127.00K 0.05%
0.05%
Add
37 20.00K $84.20K 0.03%
0.03%
New
38 701.70K $50.00K 0.02%
0.02%
Reduce
39 10.00K $23.50K 0.01%
0.01%
New

FAQ

What did Rosalind Advisors, Inc. buy in 2026-Q3?

In its 2026-Q3 13F filing, Rosalind Advisors, Inc. reported 39 equity positions worth $244.66M in aggregate; its largest disclosed positions were DCTH ($52.71M), FENC ($33.95M), HELP ($17.06M).

How large is Rosalind Advisors, Inc.'s portfolio?

Rosalind Advisors, Inc. reported $244.66M of long equity holdings across 39 positions as of 2026-Q3. Top-10 holdings account for 74.5% of reported value.

What is Rosalind Advisors, Inc.'s investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rosalind-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →